Literature DB >> 200944

Hexamethylene bisacetamide induces morphologic changes and increased synthesis of procollagen in cell line from glioblastoma multiforme.

A S Rabson, R Stern, T S Tralka, J Costa, J Wilczek.   

Abstract

Addition to hexamethylene bisacetamide (diacetyldiaminohexane) to cultures of a malignant mesenchymal cell line derived from a human glioblastoma multiforme induces morphological changes and stimulates the synthesis of procollagen. The morphological changes include cell elongation, an increase of extracellular material with staining properties of collagen by light microscopy, and an increase in extracellular 220-A fibrils by electron microscopy. The rate of procollagen synthesis increased as much as 20-fold, and the ratio of type I:type III procollagen changed, with type I becoming the predominant form. The change in type I:type III ratio is similar to that seen in the maturation of normal fetal to adult connective tissue.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200944      PMCID: PMC432098          DOI: 10.1073/pnas.74.11.5060

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  COLLAGEN SYNTHESIS BY HUMAN FIBROBLAST STRAINS.

Authors:  H GREEN; B GOLDBERG
Journal:  Proc Soc Exp Biol Med       Date:  1964-10

Review 2.  Biosynthesis of collagen. The biochemist's view.

Authors:  E J Miller; V J Matukas
Journal:  Fed Proc       Date:  1974-05

3.  Elevation of peptidylproline hydroxylase activity and collagen synthesis in spontaneous primary mammary cancers of inbred mice.

Authors:  K R Cutroneo; N A Guzman; A G Liebelt
Journal:  Cancer Res       Date:  1972-12       Impact factor: 12.701

4.  Lymphoid cell-culture line derived from lymph node of marmoset infected wtih Herpesvirus saimiri--preliminary report.

Authors:  A S Rabson; G T O'Conor; D E Lorenz; R L Kirschstein; F Y Legallais; T S Tralka
Journal:  J Natl Cancer Inst       Date:  1971-05       Impact factor: 13.506

5.  Production of procollagen by human fibroblasts in culture.

Authors:  B D Smith; P H Byers; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

6.  Altered relation of two collagen types in osteogenesis imperfecta.

Authors:  B Sykes; M J Francis; R Smith
Journal:  N Engl J Med       Date:  1977-05-26       Impact factor: 91.245

7.  Restoration of several morphological characteristics of normal fibroblasts in sarcoma cells treated with adenosine-3':5'-cyclic monphosphate and its derivatives.

Authors:  G S Johnson; R M Friedman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

8.  Ascorbate-independent proline hydroxylation resulting from viral transformation of Balb 3T3 cells and unaffected by dibutyryl cAMP treatment.

Authors:  C A Evans; B Peterkofsky
Journal:  J Cell Physiol       Date:  1976-11       Impact factor: 6.384

9.  Simultaneous synthesis of types I and III collagen by fibroblasts in culture.

Authors:  S Gay; G R Martin; P K Muller; R Timpl; K Kuhn
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

10.  Differential effects of chemical inducers on expression of beta globin genes in murine erythroleukemia cells.

Authors:  U Nudel; J E Salmon; M Terada; A Bank; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

View more
  12 in total

1.  Establishment and characterization of five cell lines derived from human malignant gliomas.

Authors:  J T Rutka; J R Giblin; D Y Dougherty; H C Liu; J R McCulloch; C W Bell; R S Stern; C B Wilson; M L Rosenblum
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  Modulation of carcinoembryonic antigen release by HT-29 colon carcinoma line in the presence of different agents.

Authors:  J Friedman; M Seger; H Levinsky; D Allalouf
Journal:  Experientia       Date:  1987-10-15

3.  Effects of hexamethylene bisacetamide on alpha-fetoprotein, albumin, and transferrin production by two rat hepatoma cell lines.

Authors:  E H Hughes; H A Schut; S S Thorgeirsson
Journal:  In Vitro       Date:  1982-02

4.  The effect of the monoamine oxidase inhibitor isocarboxazid on the canine metabolism of the cell-differentiating agent hexamethylene bisacetamide.

Authors:  B A Conley; G F Sewack; M J Egorin; B Subramanyam; J G Page; C K Grieshaber
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

5.  Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells.

Authors:  Jing Wang; Xiujie Wang; Shu Jiang; Shulan Yuan; Ping Lin; Jie Zhang; Yanrong Lu; Qi Wang; Zhujuan Xiong; Yaying Wu; Jingjing Ren; Hongliang Yang
Journal:  J Neurooncol       Date:  2006-09-06       Impact factor: 4.130

6.  Tropomyosin synthesis accompanies formation of actin filaments in embryonal carcinoma cells induced to differentiate by hexamethylene bisacetamide.

Authors:  D Paulin; J Perreau; H Jakob; F Jacob; M Yaniv
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

7.  Approaches to optimal dosing of hexamethylene bisacetamide.

Authors:  B A Conley; M J Egorin; V Sinibaldi; G Sewack; C Kloc; L Roberts; E G Zuhowski; A Forrest; D A Van Echo
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

8.  Catabolites produced by the deacetylation of hexamethylenebisacetamide play a key role in murine erythroleukaemic-cell differentiation.

Authors:  E Meilhoc; M J Moutin; H B Osborne
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

9.  Alteration of myoblast phenotype by dimethyl sulfoxide.

Authors:  A F Miranda; E G Nette; S Khan; K Brockbank; M Schonberg
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

10.  Salivary concentrations of hexamethylene bisacetamide (HMBA) in patients receiving 5-day continuous infusions.

Authors:  B A Conley; M J Egorin; E G Zuhowski; V J Sinibaldi; D E Peterson
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.